Skip to main navigation
Quantum Si
  • Technology
  • Products
  • Applications
    • Protein Identification
    • PTM Analysis
  • Resources
  • Investors
    • News
    • Events and Presentations
    • Stock Information
    • Financials
    • Governance
    • Investor Resources
  • About Us
    • Careers
    • Leadership
  • Contact Us
Select Page
h
    • Technology
    • Products
    • Applications
      • Protein Identification
      • PTM Analysis
    • Resources
    • Investors
      • News
      • Events and Presentations
      • Stock Information
      • Financials
      • Governance
      • Investor Resources
    • About Us
      • Careers
      • Leadership
    • Contact Us

News Details

  • Overview
  • News
  • Events & Presentations
    Events Presentations
  • Stock Information
    Stock Quote & Chart Analyst Coverage Historic Price Lookup
  • Financials
    Quarterly Results Annual Reports SEC Filings
  • Governance
    Governance Highlights Leadership Board of Directors Committee Composition
  • Investor Resources
    Investor FAQs Investor Email Alerts Investor Contact

Quantum-Si to Participate in the Jefferies Healthcare Conference

May 25, 2023
PDF Version

BRANFORD, Conn.--(BUSINESS WIRE)--May 25, 2023-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in the Jefferies Healthcare Conference taking place at the Marriott Marquis, New York, NY on June 7-9, 2023.

Quantum-Si’s management will present on Thursday, June 8, 2023 at 8:30 AM ET.

A live and archived webcast of the event will be available in the Investors section of the Quantum-Si website under Events & Presentations.

About Quantum-Si Incorporated

Quantum-Si, The Protein Sequencing CompanyTM, is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at www.quantum-si.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230525005333/en/

Investor Contact
Juan Avendano
ir@quantum-si.com

Media Contact
Michael Sullivan
media@quantum-si.com

Source: Quantum-Si Incorporated

  • Print Page
  • Email Alerts
  • RSS Feeds
  • Contact IR
h
© Copyright 2023 QuantumSi | All rights reserved.
Follow us
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
  • Youtube